{"issuance_frequency":"","notes_translated":{"fr":"Lorsqu'une entreprise décide de vendre un médicament ou un vaccin au Canada, elle dépose une demande auprès de Santé Canada. Une présentation de drogue nouvelle contient des renseignements scientifiques détaillés sur l'innocuité, l'efficacité et la qualité du médicament. Les examinateurs scientifiques de Santé Canada évaluent les données pour évaluer les avantages et les risques potentiels d'un médicament ou d'un vaccin. Ils examinent également les renseignements qui seront fournis aux professionnels de la santé et aux consommateurs au sujet du produit. Après l'examen, nous pouvons autoriser la vente du médicament ou du vaccin au Canada seulement si les avantages du produit l'emportent sur les risques potentiels.","en":"When a company decides it would like to sell a drug or vaccine in Canada, it files a submission with Health Canada. A new drug submission contains detailed scientific information about the drug's safety, efficacy and quality. Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also review the information that will be provided to health care practitioners and consumers about the product. After the review, we may authorize the drug or vaccine for sale in Canada only if the benefits of the product outweigh the potential risks."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"6389ea33-e025-4e23-8b02-e743157ccf22","metadata_created":"2021-08-26T18:01:36.145526","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-08-26T18:01:36.145533","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-08-26","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["COVID-19","médicaments","vaccins","autorisations de médicaments et de vaccins","présentations de nouveaux médicaments","informations scientifiques","innocuité","efficacité et qualité du médicament","examinateurs scientifiques","avantages et risques potentiels","autoriser la vente du médicament ou du vaccin"],"en":["COVID-19","drugs","vaccines","drug and vaccine authorizations","new drug submissions","scientific information","drug's safety","efficacy and quality","scientific reviewers","potential benefits and risks","authorize the drug or vaccine for sale"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Autorisations de médicament et de vaccin contre la COVID-19 : Aperçu","en":"Drug and vaccine authorizations for COVID-19: Overview"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"6389ea33-e025-4e23-8b02-e743157ccf22","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a895978c-b6c5-427d-af57-7646bf68624f","related_relationship":"","name_translated":{"fr":"Autorisations de médicament et de vaccin contre la COVID-19 : Aperçu","en":"Drug and vaccine authorizations for COVID-19: Overview"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Drug and vaccine authorizations for COVID-19: Overview","language":["en"],"created":"2021-08-26T18:01:36.275933","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization.html","last_modified":null,"position":0,"revision_id":"5e205d20-c9ba-4a42-b1fb-7090ad57f4f7","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6389ea33-e025-4e23-8b02-e743157ccf22","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4afbcc1a-6d8b-40b2-a313-13970563fabd","related_relationship":"","name_translated":{"fr":"Autorisations de médicament et de vaccin contre la COVID-19 : Aperçu","en":"Drug and vaccine authorizations for COVID-19: Overview"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Drug and vaccine authorizations for COVID-19: Overview","language":["fr"],"created":"2021-08-26T18:01:36.275939","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/autorisations.html","last_modified":null,"position":1,"revision_id":"5e205d20-c9ba-4a42-b1fb-7090ad57f4f7","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2021-07-27 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"6389ea33-e025-4e23-8b02-e743157ccf22","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"When a company decides it would like to sell a drug or vaccine in Canada, it files a submission with Health Canada. A new drug submission contains detailed scientific information about the drug's safety, efficacy and quality. Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also review the information that will be provided to health care practitioners and consumers about the product. After the review, we may authorize the drug or vaccine for sale in Canada only if the benefits of the product outweigh the potential risks.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Drug and vaccine authorizations for COVID-19: Overview","revision_id":"5e205d20-c9ba-4a42-b1fb-7090ad57f4f7"}